CN105596534A - 一种治疗小儿慢性咳嗽的口服液及制法 - Google Patents
一种治疗小儿慢性咳嗽的口服液及制法 Download PDFInfo
- Publication number
- CN105596534A CN105596534A CN201610001774.5A CN201610001774A CN105596534A CN 105596534 A CN105596534 A CN 105596534A CN 201610001774 A CN201610001774 A CN 201610001774A CN 105596534 A CN105596534 A CN 105596534A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- preparation
- cough
- almond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 101
- 208000013116 chronic cough Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims description 31
- 229940100688 oral solution Drugs 0.000 title abstract 5
- 239000003814 drug Substances 0.000 claims abstract description 34
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 24
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 23
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 23
- 235000020224 almond Nutrition 0.000 claims abstract description 23
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 21
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 21
- 241001559692 Eriosema Species 0.000 claims abstract description 21
- 241000287420 Pyrus x nivalis Species 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims description 53
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 42
- 229910052742 iron Inorganic materials 0.000 claims description 21
- 241000208296 Datura Species 0.000 claims description 20
- 241000576429 Forsythia suspensa Species 0.000 claims description 19
- 239000002775 capsule Substances 0.000 claims description 19
- 241000428813 Gomphrena Species 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241001570521 Lonicera periclymenum Species 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 10
- 239000012267 brine Substances 0.000 claims description 9
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 9
- 241000245240 Lonicera Species 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 239000003973 paint Substances 0.000 claims description 7
- 235000019991 rice wine Nutrition 0.000 claims description 7
- 239000002966 varnish Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 241000723353 Chrysanthemum Species 0.000 claims 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 4
- 244000224182 Gomphrena globosa Species 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000628997 Flos Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 208000006673 asthma Diseases 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 240000005250 Chrysanthemum indicum Species 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 7
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 210000003800 pharynx Anatomy 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000002685 pulmonary effect Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000017574 dry cough Diseases 0.000 description 5
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010065563 Eosinophilic bronchitis Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 241000220324 Pyrus Species 0.000 description 4
- 201000004897 cough variant asthma Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 235000021017 pears Nutrition 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010016326 Feeling cold Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010014950 Eosinophilia Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 201000008197 Laryngitis Diseases 0.000 description 2
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 239000004870 Styrax Substances 0.000 description 2
- 244000028419 Styrax benzoin Species 0.000 description 2
- 235000000126 Styrax benzoin Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010047924 Wheezing Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000036428 airway hyperreactivity Effects 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- OBRNDARFFFHCGE-QDSVTUBZSA-N arformoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-QDSVTUBZSA-N 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000024798 heartburn Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000001107 psychogenic effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000471262 Ardisia japonica Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 229910001369 Brass Chemical group 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000029523 Interstitial Lung disease Diseases 0.000 description 1
- 208000029951 Laryngeal disease Diseases 0.000 description 1
- 241001226158 Lastreopsis Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 244000132436 Myrica rubra Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 208000026344 Nasal disease Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007920 Neurogenic Inflammation Diseases 0.000 description 1
- 208000030880 Nose disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000003174 Panax japonicus Nutrition 0.000 description 1
- 241000168720 Panax japonicus Species 0.000 description 1
- 240000002813 Parthenocissus heterophylla Species 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000004274 Sarcandra glabra Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010070488 Upper-airway cough syndrome Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000010951 brass Chemical group 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- -1 class Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000193 formoterol fumarate Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ZXJFZSBPAUJZNO-UHFFFAOYSA-N n-(1-adamantyl)-3,4-dihydroxybenzamide Chemical compound C1=C(O)C(O)=CC=C1C(=O)NC1(C2)CC(C3)CC2CC3C1 ZXJFZSBPAUJZNO-UHFFFAOYSA-N 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 238000009613 pulmonary function test Methods 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical group 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗小儿慢性咳嗽的口服液,取下述重量配比的主要原料制备而成:杏仁5-15份,甘草10-20份,桂枝3-9份,橙子3-7份,雪梨1-5份,菊花3-8份,猪仔笠1-5份,千日红5-15份,枇杷叶4-10份,金银花2-6份,连翘1-5份,洋金花3-8份。本发明药材药源易得,成本低廉,所选药材多为药性平和之物,长期使用也不会给使用者增加经济和身体上的负担。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种治疗小儿慢性咳嗽的口服液及制备方法。
背景技术
慢性咳嗽的定义目前认为咳嗽时间持续≥8周以上,X线胸片无明显肺疾病证据的咳嗽称为慢性咳嗽,咳嗽往往是患者惟一就诊症状。慢性咳嗽是呼吸系统常见的临床症状之一。
病因:1.各种鼻、咽、喉疾病引起咳嗽鼻部疾病引起分泌物倒流鼻后和咽喉等部位,直接或间接刺激咳嗽感受器,导致以咳嗽为主要表现的综合征被称为鼻后滴漏综合征(PNDS)。由于目前无法明确是否引起上呼吸道咳嗽感受器所致,2006年美国咳嗽诊治指南建议用上气道咳嗽综合征(UACS)替代PNDS。UACS是引起慢性咳嗽最常见病因之一,除了鼻部疾病外,UACS还常与咽喉部的疾病有关,如变应性或非变应性咽炎、喉炎、咽喉部新生物、慢性扁桃体炎等。它的特点是发作性或持续性咳嗽,以白天咳嗽为主,入睡后较少咳嗽,鼻后滴流和(或)咽后壁黏液附着感,有鼻炎、鼻窦炎、鼻息肉或慢性咽喉炎等病史,检查发现咽后壁有黏液附着、鹅卵石样观。慢性鼻窦炎影像学可见鼻窦黏膜增厚、鼻窦内出现液平面。普通感冒引起咳嗽也可能是分泌物沿鼻后滴流刺激所致。由于普通感冒是人类最常见的疾病,故鼻后滴流综合征是引起咳嗽最常见的原因之一。近年来随着气候变迁,大气污染加重,患者叠进感冒药、滥用抗生素等,使本病发病日趋增多。2.胃食管反流性咳嗽因胃酸和其他胃内容物反流进入食管,导致以咳嗽为突出的临床表现,属于胃食管反流病(GERD)的一种特殊类型。GERD出现食管外表现的相关机制有两种观点,一种是微吸入,另一种是食管—支气管反射引起的气道神经源性炎症,两者均可引起气道高反应。典型反流症状表现为烧心(胸骨后烧灼感)、反酸、嗳气等。部分胃食管反流引起的咳嗽伴有典型的反流症状,但有不少患者以咳嗽为惟一的表现。咳嗽是胃食管反流最常见的食管外症状之一,其次为咽球感和(或)咽部异物感、咽喉灼痛、声音嘶哑。其咳嗽多为刺激性干咳,亦可表现为有痰的咳嗽。绝大多数为白天咳嗽,个别表现为夜间咳嗽,常伴胃灼热、反酸及胸痛、恶心等消化系统症状。但临床上也有不少患者完全没有反流症状,咳嗽是其惟一的临床表现。24小时食管Ph监测可以诊断。其机理不清,可能与咽、喉、气管的咳嗽受体受反流物刺激有关。使用制酸剂或促胃肠动力药或H2受体阻止剂、质子泵抑制剂可迅速减轻症状,治疗时间要求3个月以上,一般需2~4周方显疗效。3.“哮喘”引起咳嗽-咳嗽变异性哮喘(CVA)如果咳嗽超过2个月,则应考虑变异型哮喘的可能。是一种特殊类型的哮喘,咳嗽是其惟一或主要临床表现,无明显喘息、气促等症状或体征,但有气道高反应性。其诊断标准是:慢性咳嗽常伴有明显的夜间刺激性咳嗽;支气管激发试验阳性或呼气峰流速(PEF)昼夜变异率>20%;支气管扩张剂治疗有效;排除其他原因引起的慢性咳嗽。4.嗜酸粒细胞性支气管炎(EB)引起咳嗽由一种以气道嗜酸粒细胞浸润为特征的非哮喘性支气管炎。临床表现缺乏特征性,多为慢性刺激性干咳或咳少许黏痰,可在白天或夜间咳嗽,部分患者对油烟、灰尘、异味或冷空气比较敏感,常为咳嗽的诱发因素。诱导痰中嗜酸粒细胞增多,肺通气功能正常,无气道高反应性,PEF日间变异率正常。痰细胞学检查嗜酸粒细胞比例≥2.5%;排除其他嗜酸粒细胞增多性疾病;口服或吸入糖皮质激素有效,支气管扩张剂治疗无效。就诊前患者多数病程超过3个月,甚至长达数年以上。部分患者与吸入变应原有关,如尘螨、花粉、蘑菇孢子等,也有与职业性接触化学试剂或化学制品有关,如橡胶手套、丙烯酸盐等。通常采用ICS治疗,丙酸倍氯米松或等效剂量的其他糖皮质激素,每天2次,持续应用4周以上,推荐使用干粉吸入剂;初始治疗可联合应用泼尼松口服。5.变应性咳嗽(AC)目前尚无公认的标准,以下标准供参考:(1)慢性咳嗽,多为刺激性干咳;(2)肺通气功能正常,支气管激发试验阴性;(3)具有下列指征之一:①有过敏性疾病史或过敏物质接触史;②变应原皮试阳性;③血清总IgE或特异性IgE增高;④咳嗽敏感性增高。抗组胺药物治疗有一定效果,必要时加用吸入或短期(3~7天)口服糖皮质激素。上述情况为引起慢性咳嗽的最常见的病因,除上述情况外,还有其他几种引起咳嗽的原因。不少间质性肺病在早期往往以干咳为主要症状,这种情况下肺功能检查有助于早期发现;药物性引起的咳嗽常见于ACEI、β受体阻滞剂,发病率在15%左右。服药后24小时或数月后发生,女多于男,可能与提高咳嗽感受器的敏感性有关。停药数日至4周后缓解;在除外这些因素后,可考虑心因性咳嗽,与紧张、焦虑、悲伤等负面情绪有关。其特点是咳嗽呈犬吠样或雁鸣样、刺激性干咳,常伴清喉音。咳嗽与进食、饮水均无关系。感染性咳嗽可以逐渐演变成为心因性咳嗽。临床表现临床表现结合导致咳嗽的不同病因可见相应临床症状。
在现有治疗小儿慢性咳嗽的中药或者食品中,授权公告号CN103610845B(申请号201310651424.X)的专利文献公开了一种治疗小儿慢性咳嗽的药物的制备方法,其特征在于,该方法包括下列步骤:取大鳞毛蕨6克、杜仲9克、唇香草3克、没药8克、菊花9克、黄葵6克、蛇白蔹3克、白术5克、猪仔笠2克、绿豆9克、紫麻3克、温大青5克、杨梅2克、榉树皮2克、桃花6克、碗花草3克和三枝叶2克,加入水8000毫升,在装有冷凝管的烧瓶中在90℃下加热5小时,过滤,收集滤液。授权公告号CN103463376B(申请号201310401068.6)的专利文献公开了一种治疗小儿慢性咳嗽的中药制剂,其特征在于该中药制剂由以下重量的中药制成:矮地茶9g、瓜子金16g、百药煎7g、竹根七10g、肿节风15g、雪里开9g、洋金花0.2g、珠子参8g、甘草3g,按传统的方法水煎制成汤剂。
由此可见,中药在治疗小儿慢性咳嗽方面占有非常重要的地位,但是专利文献中,没有专门用于治疗小儿慢性咳嗽的口服液。
发明内容
针对现有技术的不足,本发明的目的之一在于提供治疗小儿慢性咳嗽的口服液,本发明药材药源易得,成本低廉,所选药材多为药性平和之物,中药材和水果组合在一起制备成的口服液,长期使用也不会给使用者增加经济和身体上的负担。
本发明的另一目的就是提供上述口服液的制备方法。
本发明的技术方案是:
一种治疗小儿慢性咳嗽的口服液,取下述重量配比的主要原料制备而成:杏仁5-15份,甘草10-20份,桂枝3-9份,橙子3-7份,雪梨1-5份,菊花3-8份,猪仔笠1-5份,千日红5-15份,枇杷叶4-10份,金银花2-6份,连翘1-5份,洋金花3-8份。
一种治疗小儿慢性咳嗽的口服液,优选的方案为,取下述重量配比的主要原料制备而成:杏仁8-13份,甘草13-18份,桂枝5-7份,橙子4-6份,雪梨2-4份,菊花4-7份,猪仔笠2-4份,千日红8-13份,枇杷叶6-8份,金银花3-5份,连翘2-4份,洋金花4-7份。
一种治疗小儿慢性咳嗽的口服液,更为优选的方案为,取下述重量配比的主要原料制备而成:杏仁10份,甘草15份,桂枝6份,橙子5份,雪梨3份,菊花5.5份,猪仔笠3份,千日红10份,枇杷叶7份,金银花4份,连翘3份,洋金花5份。
上述口服液的制备方法,步骤如下:
(1)将菊花洗净,置于透明的容器内,加入80-100℃热水浸泡两次,每次浸泡15-28分钟,过滤,两次滤液混匀待用;
(2)将杏仁用淡盐水浸泡2-4小时,取出置于烤箱内烤制酥脆,研磨成细末过80-120目筛待用;
(3)将甘草、桂枝、猪仔笠、千日红、枇杷叶、金银花、连翘和洋金花用黄酒拌匀,用保鲜膜包裹置于20-40℃的环境下焖3-8小时,取一块干净的铁板,用刷子将油刷在铁板上,然后再将制备好的原料药平铺在铁板上,小火慢烘4-9分钟,晾至酥脆,研磨成细末,过80-120目筛待用;
(4)将橙子去皮与雪梨一同切块置于干净的容器内,加入步骤(1)所得滤液,浸泡20-48分钟,然后放入步骤(2)-(3)所得细末,拌匀,置于蒸笼上蒸制60-80分钟,取出用白糖拌匀,放凉即得口服液。
上述口服液的制备方法,步骤(1)加入85-95℃热水浸泡两次,每次浸泡18-25分钟(优选的,加入90℃热水浸泡两次,每次浸泡21分钟)。
上述口服液的制备方法,步骤(2)将杏仁用淡盐水浸泡2.5-3.5小时(优选的,将杏仁用淡盐水浸泡3小时)。
上述口服液的制备方法,步骤(2)研磨成细末过90-110目筛待用(优选的,研磨成细末过100目筛待用)。
上述口服液的制备方法,步骤(3)用保鲜膜包裹置于25-35℃的环境下焖4-7小时(优选的,用保鲜膜包裹置于30℃的环境下焖5.5小时)。
上述口服液的制备方法,步骤(3)小火慢烘5-8分钟,晾至酥脆(优选的,小火慢烘7分钟,晾至酥脆)。
上述口服液的制备方法,步骤(4)置于蒸笼上蒸制65-75分钟(优选的,置于蒸笼上蒸制70分钟)。
最佳使用方法:为使本发明达到最佳的治疗效果,制成的口服液,每次服用3-5ml,一日3次,温开水送服。
各原料药的药理功效分别为:
杏仁:本品主入肺经。味苦能降,且兼疏利开通之性,降肺气之中兼有宣肺之功而达止咳平喘,为治咳喘之要药。苦杏仁苷分解产生的苯甲醛静安息香缩合酶作用生成安息香。安息香具有镇痛作用,因此国内有人用苦杏仁治疗晚期肝癌可解除病人的痛苦,有的甚至不需服用止痛药。
甘草:气微,味甜而特殊。功能主治清热解毒、祛痰止咳、脘腹等。
桂枝:其性味辛、甘,温,入肺、心、膀胱经,是主治里寒常用的温里药,具有补元阳、通血脉、暖脾胃之功效,常与补肝肾药、补气血药配伍,治疗肾阳不足、命门火衰、肢冷脉微,与其它温里药配伍治疗脘腹冷痛、寒痹腰痛,具有明显的镇痛和抗癌防癌的作用。现有的各种驱风油类药物如清凉油、风湿油等皆含有桂油成分。功能:桂枝能发汗解肌,温经通脉,助阳化气,散寒止痛。主风寒表证;寒湿痹痛;四肢厥冷;经闭痛经;症瘕结块;胸痹;心悸;痰饮;小便不利。用于风寒感冒,脘腹冷痛,血寒经闭,关节痹痛,痰饮,水肿,心悸,奔豚。
橙子:味甘、酸,性微凉。能生津止渴,助消化,和胃。含柠檬酸、苹果酸、琥珀酸、糖类、果胶、维生素C等成分。用于胃阴不足,口渴心烦,饮酒过度;消化不良,胃气不和,恶心呕逆。
雪梨:它药用能治风热、润肺、凉心、消痰、降火、解毒。医学研究证明,梨确有润肺清燥、止咳化痰、养血生肌的作用。因此对急性气管炎和上呼吸道感染的患者出现的咽喉干、痒、痛、音哑、痰稠、便秘、尿赤、祛痰均有良效。梨又有降低血压和养阴清热的效果,所以高血压、肝炎、肝硬化病人常吃梨有好处。味甘性寒,具生津润燥、清热化痰、养血生肌之功效,特别适合秋天食用。梨可以生吃,也可以蒸,还可以做成汤和羹。
菊花:由菊花与猪肉、蛇肉炒或与鱼肉、鸡肉煮食的“菊花肉片”,荤中有素,补而不腻,清心爽口,可用于头晕目眩、风热上扰之症的治疗。将菊花、陈艾叶捣碎为粗末,装入纱布袋中,做成护膝,可祛风除湿、消肿止痛,治疗鹤膝风等关节炎。有疏风、平肝之功,嗅之,对感冒、头痛有辅助治疗作用。
猪仔笠:清肺化痰。治肺热咳嗽,烦渴,赤白痢疾。①《生草药性备要》:止咳化痰,润肺滋肾。②《广西中药志》:"清心肺,生津止渴,治肺热咳嗽,湿热腹痛。
千日红:性味:性平,味甘。药理作用:其皂甙和黄铜部分能祛痰。功能主治:花序入药,有止咳祛痰、定喘、平肝明目功效,主治支气管哮喘,急、慢性支气管炎,百日咳,肺结核咯血等症。
枇杷叶:味苦、微辛,性微寒;归肺、胃经,微香清降。1、清肺祛痰:本品苦寒,能清肺热,降肺气以止咳,常用于治疗肺热咳嗽、痰多色黄。2、和胃降逆:可降胃气而止呕逆,用于胃热引起的呕逆。3、止渴:本品可治疗口干消渴,肺风面疮,粉刺。本品味苦,性微寒,主入肺、胃经,善降肺胃气逆而止咳、止呕,为痰热咳嗽及胃热呕逆所常用。
金银花:现代研究证明,金银花含有绿原酸、木犀草素苷等药理活性成分,对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病病毒等有较强的抑制力,另外还可增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇等,其临床用途非常广泛,可与其它药物配伍用于治疗呼吸道感染、菌痢、急性泌尿系统感染、高血压等40余种病症。
连翘:功能主治:清热,解毒,散结,消肿。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭。
洋金花:性味:呸辛;性温;有毒,归经:归心、肺、脾经。功效主治:止咳平喘,止痛镇静。哮喘咳嗽,脘腹冷痛,风湿痹痛,小儿慢惊;外科麻醉。
本发明口服液“注重整体”,既可治疗小儿慢性咳嗽,又可改善食欲,最主要的是将中药材与水果组合在一起,这是有别于药物治疗的一大特点,本口服液完全根据中医中药原理制备而成,更加安全可靠,无任何毒副作用,对基体无任何刺激。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1治疗小儿慢性咳嗽的口服液,取下述重量配比的主要原料制备而成(每份取10g):杏仁5份,甘草10份,桂枝3份,橙子3份,雪梨1份,菊花3份,猪仔笠1份,千日红5份,枇杷叶4份,金银花2份,连翘1份,洋金花3份。
上述口服液的制备方法,制备步骤如下:
(1)将菊花洗净,置于透明的容器内,加入80℃热水浸泡两次,每次浸泡15分钟,过滤,两次滤液混匀待用;
(2)将杏仁用淡盐水浸泡2小时,取出置于烤箱内烤制酥脆,研磨成细末过80目筛待用;
(3)将甘草、桂枝、猪仔笠、千日红、枇杷叶、金银花、连翘和洋金花用黄酒拌匀,用保鲜膜包裹置于20℃的环境下焖3小时,取一块干净的铁板,用刷子将油刷在铁板上,然后再将制备好的原料药平铺在铁板上,小火慢烘4分钟,晾至酥脆,研磨成细末,过80目筛待用;
(4)将橙子去皮与雪梨一同切块置于干净的容器内,加入步骤(1)所得滤液,浸泡20分钟,然后放入步骤(2)-(3)所得细末,拌匀,置于蒸笼上蒸制60分钟,取出用白糖拌匀,放凉即得口服液。
典型病例一:王XX,男,3岁,是济南人,2013年秋天患者来诊,连续咳嗽2个月,X射线检查显示胸片正常,白细胞总数正常,主要症状有反复咳嗽,严重影响正常睡眠,伴随胸闷、流涕,医生建议使用本发明所得治疗小儿慢性咳嗽的口服液。
使用本实施例1所得口服液,各临床症状明显好转,用药10天后,咳嗽等临床症状消失,双肺呼吸音清,哮鸣音消失,随后半年回访无复发。
实施例2治疗小儿慢性咳嗽的口服液,取下述重量配比的主要原料制备而成(每份取5g):杏仁15份,甘草20份,桂枝9份,橙子7份,雪梨5份,菊花8份,猪仔笠5份,千日红15份,枇杷叶10份,金银花6份,连翘5份,洋金花8份。
上述口服液的制备方法,制备步骤如下:
(1)将菊花洗净,置于透明的容器内,加入100℃热水浸泡两次,每次浸泡28分钟,过滤,两次滤液混匀待用;
(2)将杏仁用淡盐水浸泡4小时,取出置于烤箱内烤制酥脆,研磨成细末过120目筛待用;
(3)将甘草、桂枝、猪仔笠、千日红、枇杷叶、金银花、连翘和洋金花用黄酒拌匀,用保鲜膜包裹置于40℃的环境下焖8小时,取一块干净的铁板,用刷子将油刷在铁板上,然后再将制备好的原料药平铺在铁板上,小火慢烘9分钟,晾至酥脆,研磨成细末,过120目筛待用;
(4)将橙子去皮与雪梨一同切块置于干净的容器内,加入步骤(1)所得滤液,浸泡48分钟,然后放入步骤(2)-(3)所得细末,拌匀,置于蒸笼上蒸制80分钟,取出用白糖拌匀,放凉即得口服液。
实施例3治疗小儿慢性咳嗽的口服液,取下述重量配比的主要原料制备而成(每份取15g):杏仁8份,甘草13份,桂枝5份,橙子4份,雪梨2份,菊花4份,猪仔笠2份,千日红8份,枇杷叶6份,金银花3份,连翘2份,洋金花4份。
述口服液的制备方法,制备步骤如下:
(1)将菊花洗净,置于透明的容器内,加入85℃热水浸泡两次,每次浸泡18分钟,过滤,两次滤液混匀待用;
(2)将杏仁用淡盐水浸泡2.5小时,取出置于烤箱内烤制酥脆,研磨成细末过90目筛待用;
(3)将甘草、桂枝、猪仔笠、千日红、枇杷叶、金银花、连翘和洋金花用黄酒拌匀,用保鲜膜包裹置于25℃的环境下焖4小时,取一块干净的铁板,用刷子将油刷在铁板上,然后再将制备好的原料药平铺在铁板上,小火慢烘5分钟,晾至酥脆,研磨成细末,过90目筛待用;
(4)将橙子去皮与雪梨一同切块置于干净的容器内,加入步骤(1)所得滤液,浸泡30分钟,然后放入步骤(2)-(3)所得细末,拌匀,置于蒸笼上蒸制65分钟,取出用白糖拌匀,放凉即得口服液。
实施例4治疗小儿慢性咳嗽的口服液,取下述重量配比的主要原料制备而成(每份取20g):杏仁13份,甘草18份,桂枝7份,橙子6份,雪梨4份,菊花7份,猪仔笠4份,千日红13份,枇杷叶8份,金银花5份,连翘4份,洋金花7份。
上述口服液的制备方法,制备步骤如下:
(1)将菊花洗净,置于透明的容器内,加入95℃热水浸泡两次,每次浸泡25分钟,过滤,两次滤液混匀待用;
(2)将杏仁用淡盐水浸泡3.5小时,取出置于烤箱内烤制酥脆,研磨成细末过110目筛待用;
(3)将甘草、桂枝、猪仔笠、千日红、枇杷叶、金银花、连翘和洋金花用黄酒拌匀,用保鲜膜包裹置于35℃的环境下焖7小时,取一块干净的铁板,用刷子将油刷在铁板上,然后再将制备好的原料药平铺在铁板上,小火慢烘8分钟,晾至酥脆,研磨成细末,过110目筛待用;
(4)将橙子去皮与雪梨一同切块置于干净的容器内,加入步骤(1)所得滤液,浸泡38分钟,然后放入步骤(2)-(3)所得细末,拌匀,置于蒸笼上蒸制75分钟,取出用白糖拌匀,放凉即得口服液。
典型病例二:黄XX,女,5岁,山东济南人士,患有慢性咳嗽2个月,表现为反复咳嗽,胸闷、气喘、鼻塞、流涕、神疲气短,双肺呼吸音粗可闻,所以医生建议使用本发明所得治疗小儿慢性咳嗽的口服液。
使用本实施例4所得口服液,10天后,咳嗽等临床症状消失,双肺呼吸音清,哮鸣音消失,又继续服用5天,自感痊愈。
实施例5治疗小儿慢性咳嗽的口服液,取下述重量配比的主要原料制备而成(每份取30g):杏仁10份,甘草15份,桂枝6份,橙子5份,雪梨3份,菊花5.5份,猪仔笠3份,千日红10份,枇杷叶7份,金银花4份,连翘3份,洋金花5份。
上述口服液的制备方法,制备步骤如下:
(1)将菊花洗净,置于透明的容器内,加入90℃热水浸泡两次,每次浸泡21分钟,过滤,两次滤液混匀待用;
(2)将杏仁用淡盐水浸泡3小时,取出置于烤箱内烤制酥脆,研磨成细末过100目筛待用;
(3)将甘草、桂枝、猪仔笠、千日红、枇杷叶、金银花、连翘和洋金花用黄酒拌匀,用保鲜膜包裹置于30℃的环境下焖5.5小时,取一块干净的铁板,用刷子将油刷在铁板上,然后再将制备好的原料药平铺在铁板上,小火慢烘7分钟,晾至酥脆,研磨成细末,过100目筛待用;
(4)将橙子去皮与雪梨一同切块置于干净的容器内,加入步骤(1)所得滤液,浸泡34分钟,然后放入步骤(2)-(3)所得细末,拌匀,置于蒸笼上蒸制70分钟,取出用白糖拌匀,放凉即得口服液。
试验例1实施例5所得治疗小儿慢性咳嗽的口服液的临床应用:在4所医院筛选100例患者,首次就诊反复咳嗽时间4周-1年,其中咳嗽变异性哮喘(CVA)26例,上气道咳嗽综合征(UACS)21例,感染后咳嗽(PIC)15例,胃食管反流性咳嗽(GERC)13例,肺炎支原体感染11例,变应性咳嗽(AC)7例,嗜酸粒细胞性支气管炎(EB)4例,支气管异物2例,心因性咳嗽1例,试验之前5天,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组使用实施例5所得产品,对照组使用其它药品。
疗效情况判定标准:有效:服用本品后,不适症状消失;无效:服用本品后,身体状况无变化。结果如表1所示。
表1:使用实施例5所得口服液效果验证
实验组 | 对照组 | |
例数 | 50 | 50 |
显效例数 | 48 | 35 |
无效例数 | 2 | 15 |
显效率 | 96% | 70% |
治疗效果:显效48例(96%),无效2例(4%),显效率96%,效果明显优于对照组。且无效中的2人在继续使用一段时间后,咳嗽消失,抵抗力有所改善,因此不排除因使用时间短而使结果有所偏差,使用期间,无一人出现不适症状或副作用。
Claims (10)
1.一种治疗小儿慢性咳嗽的口服液,其特征在于:取下述重量配比的主要原料制备而成:杏仁5-15份,甘草10-20份,桂枝3-9份,橙子3-7份,雪梨1-5份,菊花3-8份,猪仔笠1-5份,千日红5-15份,枇杷叶4-10份,金银花2-6份,连翘1-5份,洋金花3-8份。
2.根据权利要求1所述的治疗小儿慢性咳嗽的口服液,其特征在于:取下述重量配比的主要原料制备而成:杏仁8-13份,甘草13-18份,桂枝5-7份,橙子4-6份,雪梨2-4份,菊花4-7份,猪仔笠2-4份,千日红8-13份,枇杷叶6-8份,金银花3-5份,连翘2-4份,洋金花4-7份。
3.根据权利要求1所述的治疗小儿慢性咳嗽的口服液,其特征在于:取下述重量配比的主要原料制备而成:杏仁10份,甘草15份,桂枝6份,橙子5份,雪梨3份,菊花5.5份,猪仔笠3份,千日红10份,枇杷叶7份,金银花4份,连翘3份,洋金花5份。
4.根据权利要求1-3任一项所述治疗小儿慢性咳嗽的口服液的制备方法,其特征在于:步骤如下:
(1)将菊花洗净,置于透明的容器内,加入80-100℃热水浸泡两次,每次浸泡15-28分钟,过滤,两次滤液混匀待用;
(2)将杏仁用淡盐水浸泡2-4小时,取出置于烤箱内烤制酥脆,研磨成细末过80-120目筛待用;
(3)将甘草、桂枝、猪仔笠、千日红、枇杷叶、金银花、连翘和洋金花用黄酒拌匀,用保鲜膜包裹置于20-40℃的环境下焖3-8小时,取一块干净的铁板,用刷子将油刷在铁板上,然后再将制备好的原料药平铺在铁板上,小火慢烘4-9分钟,晾至酥脆,研磨成细末,过80-120目筛待用;
(4)将橙子去皮与雪梨一同切块置于干净的容器内,加入步骤(1)所得滤液,浸泡20-48分钟,然后放入步骤(2)-(3)所得细末,拌匀,置于蒸笼上蒸制60-80分钟,取出用白糖拌匀,放凉即得口服液。
5.根据权利要求4所述口服液的制备方法,其特征在于:步骤(1)加入85-95℃热水浸泡两次,每次浸泡18-25分钟(优选的,加入90℃热水浸泡两次,每次浸泡21分钟)。
6.根据权利要求4所述口服液的制备方法,其特征在于:步骤(2)将杏仁用淡盐水浸泡2.5-3.5小时(优选的,将杏仁用淡盐水浸泡3小时)。
7.根据权利要求4所述口服液的制备方法,其特征在于:步骤(2)研磨成细末过90-110目筛待用(优选的,研磨成细末过100目筛待用)。
8.根据权利要求4所述口服液的制备方法,其特征在于:步骤(3)用保鲜膜包裹置于25-35℃的环境下焖4-7小时(优选的,用保鲜膜包裹置于30℃的环境下焖5.5小时)。
9.根据权利要求4所述口服液的制备方法,其特征在于:步骤(3)小火慢烘5-8分钟,晾至酥脆(优选的,小火慢烘7分钟,晾至酥脆)。
10.根据权利要求4所述口服液的制备方法,其特征在于:步骤(4)置于蒸笼上蒸制65-75分钟(优选的,置于蒸笼上蒸制70分钟)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610001774.5A CN105596534A (zh) | 2016-01-05 | 2016-01-05 | 一种治疗小儿慢性咳嗽的口服液及制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610001774.5A CN105596534A (zh) | 2016-01-05 | 2016-01-05 | 一种治疗小儿慢性咳嗽的口服液及制法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105596534A true CN105596534A (zh) | 2016-05-25 |
Family
ID=55977263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610001774.5A Pending CN105596534A (zh) | 2016-01-05 | 2016-01-05 | 一种治疗小儿慢性咳嗽的口服液及制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105596534A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112655953A (zh) * | 2020-12-18 | 2021-04-16 | 重庆八零四零生物工程研究院有限公司 | 一种脐橙综合酵素 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1285219A (zh) * | 1999-08-24 | 2001-02-28 | 梁有廷 | 生血龙精 |
CN101219203A (zh) * | 2008-01-29 | 2008-07-16 | 喻政民 | 一种治疗咳喘和肺结核的中成药 |
CN102772758A (zh) * | 2012-06-30 | 2012-11-14 | 孟磊 | 一种风寒型急性支气管炎用中药 |
CN103463601A (zh) * | 2013-09-03 | 2013-12-25 | 薛玉秀 | 治疗脾肾阳虚型慢性支气管炎的中药制剂及制备方法 |
CN103860853A (zh) * | 2012-12-17 | 2014-06-18 | 陕西医药控股集团天宁制药有限责任公司 | 一种治疗气喘的中药组合物及其制备方法 |
-
2016
- 2016-01-05 CN CN201610001774.5A patent/CN105596534A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1285219A (zh) * | 1999-08-24 | 2001-02-28 | 梁有廷 | 生血龙精 |
CN101219203A (zh) * | 2008-01-29 | 2008-07-16 | 喻政民 | 一种治疗咳喘和肺结核的中成药 |
CN102772758A (zh) * | 2012-06-30 | 2012-11-14 | 孟磊 | 一种风寒型急性支气管炎用中药 |
CN103860853A (zh) * | 2012-12-17 | 2014-06-18 | 陕西医药控股集团天宁制药有限责任公司 | 一种治疗气喘的中药组合物及其制备方法 |
CN103463601A (zh) * | 2013-09-03 | 2013-12-25 | 薛玉秀 | 治疗脾肾阳虚型慢性支气管炎的中药制剂及制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112655953A (zh) * | 2020-12-18 | 2021-04-16 | 重庆八零四零生物工程研究院有限公司 | 一种脐橙综合酵素 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104096110A (zh) | 消除吸烟引起的口臭的漱口水及制备方法 | |
CN103518912B (zh) | 一种治疗慢性咽炎的中药保健茶及其制备方法 | |
CN104940485A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN107625828A (zh) | 一种用于辅助治疗慢性咽炎的保健茶、制备方法及应用 | |
CN104257763B (zh) | 一种肉苁蓉水提取物、制备方法及其用途 | |
CN103893737B (zh) | 用于治疗支气管哮喘的药物及其制备方法 | |
CN106693035B (zh) | 植物抑菌除味功能的卫生巾芯片 | |
CN101342331B (zh) | 治疗肺炎和上呼吸道感染的中药喷剂 | |
CN105596534A (zh) | 一种治疗小儿慢性咳嗽的口服液及制法 | |
CN108686058A (zh) | 七窍通鼻炎喷剂及其制备方法 | |
CN105125837A (zh) | 一种减轻支气管哮喘发作时气喘的喷雾剂及制备方法 | |
CN104147575A (zh) | 一种治疗风寒闭肺型慢性支气管炎的中药制剂及其制备方法 | |
CN104474045A (zh) | 治疗幼儿高热惊厥的中药贴及制备方法 | |
KR20130014768A (ko) | 소아 아토피 치료용 한약 조성물 및 이의 제조방법 | |
CN110115739A (zh) | 一种治疗病毒感染性疾病或咳嗽变异型哮喘的中药组合物及其制备方法 | |
CN108143944A (zh) | 一种治疗伤风的中药组合物 | |
CN106511882A (zh) | 可治疗预防咳嗽和哮喘的中药配方及中药香囊的制备方法 | |
CN105709086A (zh) | 一种清咽利喉袋泡茶及制备方法 | |
CN105920443A (zh) | 一种治疗支气管哮喘或肺气肿的药及其制备方法 | |
CN104906439A (zh) | 一种用于治疗慢性呼吸衰竭的药物 | |
CN104800687A (zh) | 一种治疗小儿疳积的中药剂及其制备方法 | |
CN104398902A (zh) | 虚寒型慢性支气管炎清热宣肺制剂及制法 | |
CN104888172B (zh) | 治疗过敏性咳嗽的姜葱止咳制剂及应用 | |
CN104398777A (zh) | 一种用于治疗支气管哮喘的中药 | |
CN104127659A (zh) | 一种用于治疗慢性咽炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160525 |
|
RJ01 | Rejection of invention patent application after publication |